What are the latest treatment options for breast cancer

Breast CancerOctober 15, 2025Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

I'll help explain the current treatment options for breast cancer, citing the most recent authoritative guidelines.

According to the NCCN (National Comprehensive Cancer Network) 2023 Breast Cancer Guidelines, the main treatment options depend on several factors, including:

  • Cancer stage
  • Hormone receptor status (ER/PR)
  • HER2 status
  • Overall health
  • Personal preferences

The American Cancer Society outlines these primary treatment approaches:

  1. Local Treatments:
  • Surgery (lumpectomy or mastectomy)
  • Radiation therapy
  1. Systemic Treatments:
  • Chemotherapy
  • Hormone therapy (for hormone receptor-positive cancers)
  • Targeted therapies (including HER2-targeted drugs)
  • Immunotherapy (for certain types)

ASCO (American Society of Clinical Oncology) 2023 guidelines specifically highlight these recent advances:

  • New targeted therapies like Enhertu (FDA-approved for HER2-low breast cancer)
  • CDK4/6 inhibitors combined with hormone therapy for advanced hormone-positive cases
  • Immunotherapy options for triple-negative breast cancer

Important note: Treatment plans are highly individualized. Your specific treatment options will depend on your unique diagnosis and characteristics of your cancer. Please discuss these options with your healthcare team to determine the best approach for your situation.

Would you like me to provide more detailed information about any of these specific treatment types?

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: